218 related articles for article (PubMed ID: 19432400)
21. Microglial exosomes facilitate α-synuclein transmission in Parkinson's disease.
Guo M; Wang J; Zhao Y; Feng Y; Han S; Dong Q; Cui M; Tieu K
Brain; 2020 May; 143(5):1476-1497. PubMed ID: 32355963
[TBL] [Abstract][Full Text] [Related]
22. Cx3cr1-deficiency exacerbates alpha-synuclein-A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease.
Castro-Sánchez S; García-Yagüe ÁJ; López-Royo T; Casarejos M; Lanciego JL; Lastres-Becker I
Glia; 2018 Aug; 66(8):1752-1762. PubMed ID: 29624735
[TBL] [Abstract][Full Text] [Related]
23. Identification of a specific α-synuclein peptide (α-Syn 29-40) capable of eliciting microglial superoxide production to damage dopaminergic neurons.
Wang S; Chu CH; Guo M; Jiang L; Nie H; Zhang W; Wilson B; Yang L; Stewart T; Hong JS; Zhang J
J Neuroinflammation; 2016 Jun; 13(1):158. PubMed ID: 27329107
[TBL] [Abstract][Full Text] [Related]
24. Metabotropic glutamate receptor 5 inhibits α-synuclein-induced microglia inflammation to protect from neurotoxicity in Parkinson's disease.
Zhang YN; Fan JK; Gu L; Yang HM; Zhan SQ; Zhang H
J Neuroinflammation; 2021 Jan; 18(1):23. PubMed ID: 33461598
[TBL] [Abstract][Full Text] [Related]
25. Microglia as modulators of exosomal alpha-synuclein transmission.
Xia Y; Zhang G; Han C; Ma K; Guo X; Wan F; Kou L; Yin S; Liu L; Huang J; Xiong N; Wang T
Cell Death Dis; 2019 Feb; 10(3):174. PubMed ID: 30787269
[TBL] [Abstract][Full Text] [Related]
26. The role of Galectin-3 in α-synuclein-induced microglial activation.
Boza-Serrano A; Reyes JF; Rey NL; Leffler H; Bousset L; Nilsson U; Brundin P; Venero JL; Burguillos MA; Deierborg T
Acta Neuropathol Commun; 2014 Nov; 2():156. PubMed ID: 25387690
[TBL] [Abstract][Full Text] [Related]
27. Reactive macrophages increase oxidative stress and alpha-synuclein nitration during death of dopaminergic neuronal cells in co-culture: relevance to Parkinson's disease.
Shavali S; Combs CK; Ebadi M
Neurochem Res; 2006 Jan; 31(1):85-94. PubMed ID: 16475001
[TBL] [Abstract][Full Text] [Related]
28. Neuromodulatory activities of CD4+CD25+ regulatory T cells in a murine model of HIV-1-associated neurodegeneration.
Liu J; Gong N; Huang X; Reynolds AD; Mosley RL; Gendelman HE
J Immunol; 2009 Mar; 182(6):3855-65. PubMed ID: 19265165
[TBL] [Abstract][Full Text] [Related]
29. miR-let-7a suppresses α-Synuclein-induced microglia inflammation through targeting STAT3 in Parkinson's disease.
Zhang J; Dongwei Zhou ; Zhang Z; Xinhui Qu ; Kunwang Bao ; Guohui Lu ; Jian Duan
Biochem Biophys Res Commun; 2019 Nov; 519(4):740-746. PubMed ID: 31547989
[TBL] [Abstract][Full Text] [Related]
30. Epothilone D inhibits microglia-mediated spread of alpha-synuclein aggregates.
Valdinocci D; Grant GD; Dickson TC; Pountney DL
Mol Cell Neurosci; 2018 Jun; 89():80-94. PubMed ID: 29673913
[TBL] [Abstract][Full Text] [Related]
31. Tolerogenic bone marrow-derived dendritic cells induce neuroprotective regulatory T cells in a model of Parkinson's disease.
Schutt CR; Gendelman HE; Mosley RL
Mol Neurodegener; 2018 May; 13(1):26. PubMed ID: 29783988
[TBL] [Abstract][Full Text] [Related]
32. Alpha-Synuclein-induced DNA Methylation and Gene Expression in Microglia.
McGregor BA; Schommer J; Guo K; Raihan MO; Ghribi O; Hur J; Porter JE
Neuroscience; 2021 Aug; 468():186-198. PubMed ID: 34082066
[TBL] [Abstract][Full Text] [Related]
33. Reactive microglia enhance the transmission of exosomal α-synuclein via toll-like receptor 2.
Xia Y; Zhang G; Kou L; Yin S; Han C; Hu J; Wan F; Sun Y; Wu J; Li Y; Huang J; Xiong N; Zhang Z; Wang T
Brain; 2021 Aug; 144(7):2024-2037. PubMed ID: 33792662
[TBL] [Abstract][Full Text] [Related]
34. Pathological α-synuclein exacerbates the progression of Parkinson's disease through microglial activation.
Zhang QS; Heng Y; Yuan YH; Chen NH
Toxicol Lett; 2017 Jan; 265():30-37. PubMed ID: 27865851
[TBL] [Abstract][Full Text] [Related]
35. Synuclein activates microglia in a model of Parkinson's disease.
Su X; Maguire-Zeiss KA; Giuliano R; Prifti L; Venkatesh K; Federoff HJ
Neurobiol Aging; 2008 Nov; 29(11):1690-701. PubMed ID: 17537546
[TBL] [Abstract][Full Text] [Related]
36. microRNA-155 Regulates Alpha-Synuclein-Induced Inflammatory Responses in Models of Parkinson Disease.
Thome AD; Harms AS; Volpicelli-Daley LA; Standaert DG
J Neurosci; 2016 Feb; 36(8):2383-90. PubMed ID: 26911687
[TBL] [Abstract][Full Text] [Related]
37. Effect of naturally occurring α-synuclein-antibodies on toxic α-synuclein-fragments.
Rabenstein M; Besong Agbo D; Wolf E; Dams J; Nicolai M; Roeder A; Bacher M; Dodel RC; Noelker C
Neurosci Lett; 2019 Jun; 704():181-188. PubMed ID: 30954607
[TBL] [Abstract][Full Text] [Related]
38. Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia.
Kim C; Ho DH; Suk JE; You S; Michael S; Kang J; Joong Lee S; Masliah E; Hwang D; Lee HJ; Lee SJ
Nat Commun; 2013; 4():1562. PubMed ID: 23463005
[TBL] [Abstract][Full Text] [Related]
39. Alpha-synuclein activates BV2 microglia dependent on its aggregation state.
Hoffmann A; Ettle B; Bruno A; Kulinich A; Hoffmann AC; von Wittgenstein J; Winkler J; Xiang W; Schlachetzki JCM
Biochem Biophys Res Commun; 2016 Oct; 479(4):881-886. PubMed ID: 27666480
[TBL] [Abstract][Full Text] [Related]
40. [Analysis of frequency of peripheral blood CD4+; CD25(high);Tregs and CD4+; CD25(low);T cells and expression of PD-1 in SLE and RA patients].
Niu Q; Huang ZC; Cai B; Wang LL; Feng WH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jan; 27(1):23-5. PubMed ID: 21208558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
